CommonSense, founded in 1999, is a privately owned company located in Caesarea, Israel. For the first 2 years the company was under the auspices of the Technological Incubators Infrastructure of the Israeli government (special "Hot-Houses" for selected bio-tech and high tech start-ups).
The vision of the founders was to develop the future panty-liner - that would monitor vaginal health for all women everywhere. We believe that in the very near future, women will refuse to wear any panty-liner which doesn't incorporate our unique built-in sensing capabilities for monitoring the vaginal natural defense system.
Intense Research & Development over the course of the last decade has resulted in 3 generations of technology being developed by the
R & D team - which has materialized into a range of diagnostic products for daily use that ameliorate the monitoring of women's vaginal and urinary tract health. Our technologies are also implemented in products that enable the prevention of pre-term deliveries by indicating possible vaginal BV infection during the early stages of pregnancy, and to detect amniotic fluid leaks during the final phase of pregnancy.
CommonSense's globally certified products are marketed worldwide to hospitals and professional health care providers as well as to end-users as OTC products.
Year 2003 - introduction of the first 2 products, based on Gen 1 technology:
Year 2007 - introduction of 3rd product:
Year 2008 - introduction of 4th product:
Year 2009 - introduction of 5th product:
Ready for mass production